Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Droxine
|
| gptkbp:activities |
thyroid hormone replacement
|
| gptkbp:appointed_by |
oral tablet
|
| gptkbp:approves |
gptkb:1955
gptkb:FDA |
| gptkbp:brand |
gptkb:Euthyrox
gptkb:Levoxyl gptkb:Synthroid |
| gptkbp:category |
gptkb:A
|
| gptkbp:contraindication |
gptkb:hospital
adrenal insufficiency thyrotoxicosis |
| gptkbp:dosage_form |
oral solution
injectable solution 25 mcg to 300 mcg daily |
| gptkbp:excretion |
urine
|
| gptkbp:financial_performance |
sensitive to light
|
| gptkbp:formulation |
sodium salt
|
| https://www.w3.org/2000/01/rdf-schema#label |
levothyroxine
|
| gptkbp:ingredients |
C15 H11 I4 N Na O4
|
| gptkbp:interacts_with |
gptkb:warfarin
antacids iron supplements calcium supplements |
| gptkbp:is_available_on |
generic drug
|
| gptkbp:is_monitored_by |
TSH levels
T4 levels |
| gptkbp:is_used_for |
hypothyroidism
|
| gptkbp:lifespan |
6 to 7 days
|
| gptkbp:metabolism |
liver
|
| gptkbp:related_to |
gptkb:T4
thyroid hormones endocrine system thyroid gland |
| gptkbp:side_effect |
headache
weight loss insomnia nervousness sweating increased appetite |
| gptkbp:storage |
room temperature
dry place |
| gptkbp:symptoms |
anxiety
fever vomiting confusion seizures chest pain diarrhea sweating tremors tachycardia |